title: Risk of endovascular treatment of brain arteriovenous malformations.
abstract: OBJECTIVE
  Independently assessed data on frequency, severity, and determinants of neurological deficits after endovascular treatment of brain arteriovenous malformations (AVMs) are scarce.
  
  
  METHODS
  From the prospective Columbia AVM Study Project, 233 consecutive patients with brain AVM receiving > or =1 endovascular treatments were analyzed. Neurological impairment was assessed by a neurologist using the Rankin Scale before and after completed endovascular therapy. Multivariate logistic regression models were used to identify demographic, clinical, and morphological predictors of treatment-related neurological deficits. The analysis included the components used in the Spetzler-Martin risk score for AVM surgery (AVM size, venous drainage pattern, and eloquence of AVM location).
  
  
  RESULTS
  The 233 patients were treated with 545 endovascular procedures. Mean follow-up time was 9.6 months (SD, 18.1 months). Two hundred patients (86%) experienced no change in neurological status after treatment, and 33 patients (14%) showed treatment-related neurological deficits. Of the latter, 5 (2%) had persistent disabling deficits (Rankin score >2), and 2 (1%) died. Increasing patient age [odds ratio (OR), 1.04; 95% confidence interval (CI), 1.01 to 1.08], number of embolizations (OR, 1.41; 95% CI, 1.16 to 1.70), and absence of a pretreatment neurological deficit (OR, 4.55; 95% CI, 1.03 to 20.0) were associated with new neurological deficits. None of the morphological AVM characteristics tested predicted treatment complications.
  
  
  CONCLUSIONS
  From independent neurological assessment and prospective data collection, our findings suggest a low rate of disabling treatment complications in this center for endovascular brain AVM treatment. Risk predictors for endovascular treatment differ from those for AVM surgery.
authors.affiliation: Stroke Center, Neurological Institute, New York Presbyterian Hospital, New York, NY, USA. ahart@zedat.fu-berlin.de
authors.forename: A
authors.initials: A
authors.lastname: Hartmann
authors.forename: J
authors.initials: J
authors.lastname: Pile-Spellman
authors.forename: C
authors.initials: C
authors.lastname: Stapf
authors.forename: R R
authors.initials: RR
authors.lastname: Sciacca
authors.forename: A
authors.initials: A
authors.lastname: Faulstich
authors.forename: J P
authors.initials: JP
authors.lastname: Mohr
authors.forename: H C
authors.initials: HC
authors.lastname: Schumacher
authors.forename: H
authors.initials: H
authors.lastname: Mast
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D016208:Databases, Factual; D003710:Demography; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D002538:Intracranial Arteriovenous Malformations / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D009422:Nervous System Diseases / Q000175:diagnosis / Q000209:etiology*; D016017:Odds Ratio; D011183:Postoperative Complications / Q000175:diagnosis / Q000209:etiology; D011446:Prospective Studies; D018570:Risk Assessment; D016896:Treatment Outcome; D014656:Vascular Surgical Procedures / Q000009:adverse effects*